PEDS-PLAN - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Request Access

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma

J. Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.. (2022). Cancer Reports. Cited 3 times. https://doi.org/10.1002/cnr2.1616
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747